Macro Group Pharmaceuticals (Macro Capital)E Past Earnings Performance
Past criteria checks 0/6
Macro Group Pharmaceuticals (Macro Capital)E's earnings have been declining at an average annual rate of -43.1%, while the Personal Products industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 12.2% per year.
Key information
-43.1%
Earnings growth rate
-43.1%
EPS growth rate
| Personal Products Industry Growth | 8.7% |
| Revenue growth rate | 12.2% |
| Return on equity | -289.0% |
| Net Margin | -51.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Macro Group Pharmaceuticals (Macro Capital)E makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 526 | -273 | 451 | 0 |
| 30 Sep 23 | 799 | 142 | 355 | 0 |
| 31 Mar 23 | 750 | 153 | 341 | 0 |
| 31 Dec 22 | 730 | 174 | 317 | 0 |
| 30 Sep 22 | 697 | 171 | 302 | 0 |
| 30 Jun 22 | 666 | 179 | 280 | 0 |
| 31 Mar 22 | 611 | 167 | 262 | 0 |
| 31 Dec 21 | 594 | 148 | 257 | 0 |
| 30 Sep 21 | 544 | 143 | 229 | 0 |
| 31 Dec 20 | 431 | 135 | 159 | 0 |
Quality Earnings: MCRO is currently unprofitable.
Growing Profit Margin: MCRO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if MCRO's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare MCRO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MCRO is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (13%).
Return on Equity
High ROE: MCRO has a negative Return on Equity (-289.03%), as it is currently unprofitable.